Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart.

[1]  F. Mitchelson,et al.  Muscarinic receptor differentiation. , 1988, Pharmacology & therapeutics.

[2]  R. A. Zeeuw,et al.  Muscarinic M2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function. , 1988, European journal of pharmacology.

[3]  J. Gies,et al.  Sialic acid is selectively involved in the interaction of agonists with M2 muscarinic acetylcholine receptors. , 1988, Biochemical and biophysical research communications.

[4]  M. Mishina,et al.  Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor , 1986, Nature.

[5]  G. Peterson,et al.  Physical properties of the purified cardiac muscarinic acetylcholine receptor. , 1986, Biochemistry.

[6]  A. Fryer,et al.  Postganglionic muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea‐pig , 1986, British journal of pharmacology.

[7]  W. Busse,et al.  In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity. , 2015, The American review of respiratory disease.

[8]  A. Fryer,et al.  Neuronal muscarinic receptors attenuate vagally‐induced contraction of feline bronchial smooth muscle , 1985, British journal of pharmacology.

[9]  D. Mash,et al.  Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. , 1985, Science.

[10]  A. Fryer,et al.  Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea‐pig , 1984, British journal of pharmacology.

[11]  G A McPherson,et al.  A practical computer-based approach to the analysis of radioligand binding experiments. , 1983, Computer programs in biomedicine.

[12]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[13]  A. Scheid,et al.  The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. , 1980, Reviews of infectious diseases.

[14]  J. Nadel,et al.  Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. , 1976, The American review of respiratory disease.

[15]  P. Palese,et al.  Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. , 1974, Virology.

[16]  R. Webster,et al.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. , 1973, Bulletin of the World Health Organization.

[17]  R. Compans,et al.  Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. , 1972, Virology.

[18]  H. Rosenthal.  A graphic method for the determination and presentation of binding parameters in a complex system. , 1967, Analytical biochemistry.

[19]  W. G. Laver,et al.  The Structure of Influenza Viruses. 3. Disruption of the Virus Particle and Separation of Neuraminidase Activity. , 1963 .

[20]  A. Shelokov,et al.  Hemadsorption (Adsorption-Hemagglutination) Test for Viral Agents in Tissue Culture with Special Reference to Influenza , 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.